Month: January 2015

PARENTS OF CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS EXPRESS STRONG WILLINGNESS TO PAY FOR BIOLOGIC THERAPIES

Toronto, ON, Canada – Biologic therapies are an expensive group of drugs increasingly being used to treat inflammatory diseases in children and adults. Coverage in publicly-financed drug plans has been inconsistent and, at a cost of over $17,000 per year,

Posted in Preference-Based Assessments, Value in Health Tagged with: , , , , ,

ISPOR 2015 SCIENTIFIC AWARDS – CALL FOR NOMINATIONS

The ISPOR Awards Committee is now accepting nominations for the Society’s annual scientific awards.  ISPOR’s Scientific Awards are designed to recognize outstanding achievements in pharmacoeconomics and outcomes research. If you would like to nominate a candidate or yourself for one

Posted in ISPOR News & Press

SUCCESS FEE: A NOVEL TOOL FOR THE SUSTAINABILITY OF NOVEL EXPENSIVE THERAPIES

Catania, Italy – To guarantee rapid patient access to high cost, innovative therapies, policy makers have introduced cost-containment strategies based on the partial or total reimbursements of a drug price. Under these agreements, market access for a drug is granted

Posted in Announcements, Policy Perspectives, Value in Health Tagged with: , , , , , , ,